Armodafinil
- Product NDC
- 0093-3090
- Requested package NDC
- 0093-3090-56
- 11-digit product format
- 000933090
- Labeler code
- 0093
- Product ID
- 0093-3090_ca66f83d-4d17-4516-9163-abdb19872555
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Armodafinil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- NDA021875
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-11-29
- Marketing end
- 2027-09-30
- Substance
- ARMODAFINIL
- Active strength
- 50 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- No
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021875-001 | NUVIGIL | ARMODAFINIL | 50MG | TABLET / ORAL | AB | RLD | 2007-06-15 |
| N021875-002 | NUVIGIL | ARMODAFINIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-03-26 | |
| N021875-003 | NUVIGIL | ARMODAFINIL | 150MG | TABLET / ORAL | AB | RLD | 2007-06-15 |
| N021875-004 | NUVIGIL | ARMODAFINIL | 250MG | TABLET / ORAL | AB | RLD, RS | 2007-06-15 |
| N021875-005 | NUVIGIL | ARMODAFINIL | 200MG | TABLET / ORAL | AB | RLD | 2009-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021875-001 | AB |
| N021875-003 | AB |
| N021875-004 | AB |
| N021875-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021875-001 | NUVIGIL | 50MG | TABLET / ORAL | AB | RLD | 2007-06-15 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-002 | NUVIGIL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-03-26 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N021875-003 | NUVIGIL | 150MG | TABLET / ORAL | AB | RLD | 2007-06-15 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-004 | NUVIGIL | 250MG | TABLET / ORAL | AB | RLD, RS | 2007-06-15 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-005 | NUVIGIL | 200MG | TABLET / ORAL | AB | RLD | 2009-03-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N021875-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N021875-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nuvigil | ARMODAFINIL | Golden State Medical Supply, Inc. | 3dd49302-f757-d945-e063-6294a90afcba | 2025-09-02 | Warnings, Adverse reactions | 021875 NDA021875 |
| Nuvigil | ARMODAFINIL | Apotex Corp. | a69631d0-1263-769e-b232-4ab9160e0fa3 | 2025-08-18 | Warnings, Adverse reactions | 021875 NDA021875 |
| ARMODAFINIL | ARMODAFINIL | DirectRx | ddd06dab-0855-5b4e-e053-2a95a90a5e67 | 2025-01-22 | Warnings, Adverse reactions | 021875 NDA021875 |
| ARMODAFINIL | ARMODAFINIL | direct rx | b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19 | 2025-01-20 | Warnings, Adverse reactions | 021875 NDA021875 |
| Armodafinil | ARMODAFINIL | Quality Care Products LLC | 98338994-7818-4b86-ae98-cd08fa700879 | 2024-12-17 | Warnings, Adverse reactions | 021875 NDA021875 |
| Armodafinil | ARMODAFINIL | Teva Pharmaceuticals USA, Inc. | b3cac300-c3d2-4189-a410-2aaf3773c090 | 2023-01-31 | Warnings, Adverse reactions | 021875 NDA021875 0093-3090-56 0093-3090 00093309056 |
| Armodafinil | ARMODAFINIL | Sandoz Inc | a3341ec8-1ad4-49e2-922b-13d1b30c8c1d | 2023-01-31 | Warnings, Adverse reactions | 021875 NDA021875 |
| Nuvigil | ARMODAFINIL | Cephalon, LLC | d878aed0-ddbf-8fa1-abf7-d3e480260845 | 2022-12-31 | Warnings, Adverse reactions | 021875 NDA021875 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Armodafinil
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ARMODAFINIL | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V63XWA605I | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b3cac300-c3d2-4189-a410-2aaf3773c090 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf31ebd7-fd9d-472c-88e1-94944f023ec0 | Product name | 3 | 20190628 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-3090-56 | Armodafinil | 30 in 1 BOTTLE | TABLET | 30 | 16 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-3090-56 | EA - Each | 0093-3090 | 9ed1a825-bb7e-4561-8caa-063ac4220da1 | 1 | 2016-12-07 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 724859 | armodafinil 150 MG Oral Tablet | PSN | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 861960 | armodafinil 200 MG Oral Tablet | PSN | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 724861 | armodafinil 250 MG Oral Tablet | PSN | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 724863 | armodafinil 50 MG Oral Tablet | PSN | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 724859 | armodafinil 150 MG Oral Tablet | SCD | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 861960 | armodafinil 200 MG Oral Tablet | SCD | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 724861 | armodafinil 250 MG Oral Tablet | SCD | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
| 724863 | armodafinil 50 MG Oral Tablet | SCD | b3cac300-c3d2-4189-a410-2aaf3773c090 | 16 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0093-3090-56 | 00093309056 | 30 TABLET in 1 BOTTLE (0093-3090-56) | 30 tablet | 2016-11-29 | 2027-09-30 | No | No | Current |